Company profile
LFTD PARTNERS INC. CIK 1391135
Ticker
LIFD (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Jacksonville, FL 32224
Fiscal year end
2025 (FY)
Key Financials
Revenue
$36.92M
Net income
-$24.86M
Total assets
$19.27M
Total liabilities
$6.64M
Stockholders' equity
$12.63M
Cash & equivalents
$1.77M
Operating income
$913.2K
Operating cash flow
$1.32M
Capital expenditures
$121.6K
Fiscal year 2025, via 10-K filed 2026-04-01. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
2.5%
Net margin
-67.3%
Free cash flow
$1.20M
Free cash flow margin
3.2%
Liabilities / assets
34.5%
Equity / assets
65.5%
CapEx / revenue
0.3%
Operating cash flow / net income
-0.05×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$36.92M
-$24.86M
$19.27M
$6.64M
$12.63M
2024
$37.33M
-$1.86M
$47.62M
$10.12M
$37.50M
2023
$51.61M
$2.16M
$51.35M
$12.53M
$38.82M
2022
$57.42M
$7.20M
$41.13M
$6.59M
$34.54M
2021
$31.66M
$5.80M
$39.42M
$11.96M
$27.46M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-14
Financials filed via
Form 10-K
filed 2026-04-01
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Jacksonville, FL 32224
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:25 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.